USPTO serial 79186358
SANTONIKA
Reviewed by CopyMark Law Group
Reg. 5298661Status 404
- Filing date
- Status date
- Registration date
- Oct 3, 2017
- Examiner
- TANNER, MICHAEL R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SANTONIKA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of psychoorganic syndrome, neuropsychiatric and psychiatric diseases, nervous system disorders, Alzheimer disease, Parkinson disease, vertigo of different origin, cardiovascular diseases, stroke, cerebrovascular stroke, vegetative-vascular dystonia, neurodegenerative diseases, neuroinfections, somatoform autonomic dysfunction, atherosclerosis, attention deficit disorder, diseases followed by abnormal changes in bioelectrical characteristics of the brain, congestive heart failure, hyperpiesis, neuroticism, psychosomatic disease, stress disorders, asthenic syndrome, neurotoxicosis and obesity; Pharmaceutical and veterinary preparations for use in the treatment of diabetes, type II diabetes, for use in the prevention of complication from diabetes, insulin resistance, parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, fungal infections, viral infections, parainfluenza, adenovirus, respiratory syncytial virus, coronavirus, labially herpes, genital herpes, chicken pox, herpes zoster, infectious mononucleosis, intestinal infections of viral etiology, including calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses, enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis, pneumonia; Pharmaceutical and veterinary preparations for use in the prevention of bacterial complications of viral infections, prevention of super bacterial infection; pharmaceutical preparations, namely, antihistamines; pharmaceutical preparations for the treatment of AIDS / HIV infection; pharmaceutical preparations, namely, psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, autonomic disturbances of menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome, functional gastrointestinal disorders; pharmaceutical preparations, namely, anticonvulsants; pharmaceutical preparations, namely, antianxiety preparations; pharmaceutical preparations, namely, cough treatment preparations; pharmaceutical preparations, namely, preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy, nonspecific ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; pharmaceutical and veterinary preparations, namely, antioxidants; pharmaceutical nootropic preparations for use in the improvement of cognitive functions, for use in the treatment of memory diseases and disorders; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose in the blood and elevated levels of glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; food for babies; dietary supplements for humans and animals; capsules sold empty for medicines; cachets for pharmaceutical purposes, namely, flat capsules sold empty for enclosing unpleasant-tasting pharmaceuticals; appetite suppressant pills | SECTION 71 - CANCELLED | — |
| 035 | Import-export agency services; cost price analysis; rental of advertising space; demonstration of goods; conducting marketing studies; consumer advice shop, namely, providing commercial information and advice for consumers; business investigations; marketing research; organization of exhibitions for commercial or advertising purposes; organization of fashion shows for promotional purposes; organization of trade fairs for commercial or advertising purposes; shop window dressing; presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; sales promotion for others; production of advertising films; publicity material rental; rental of billboards and advertising boards; bill-posting; distribution of samples for publicity purposes; dissemination of advertising matter; direct mail advertising; writing of publicity texts; on-line advertising on a computer network; advertising by mail order, namely, direct mail advertising services; telemarketing services; business management for freelance service providers; commercial administration of the licensing of the goods and services of others; administrative processing of purchase orders; modelling for advertising or sales promotion; price comparison services; pay per click advertising; procurement services for others, namely, purchasing pharmaceutical, veterinary and sanitary preparations and medical supplies for other businesses; business efficiency expert services | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research for others, technical research in the field of pharmaceutical studies, pharmaceutical research and development, pharmaceutical drug development services; industrial analysis and research services, namely, industrial research in the field of pharmaceutical drug development; design and development of computer hardware and software; water analysis; chemical analysis; industrial design; graphic arts design; engineering; clinical trials, namely, conducting clinical trials for others; material testing; bacteriological research; biological research; chemical research; research and development of new products for others; scientific research; technical research in the field of pharmaceutical studies; measuring, namely, calibration services; quality control, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of pharmaceutical medications; provision of scientific information, advice and consultancy in relation to carbon offsetting; chemistry services, namely, research in the field of chemistry, laboratory analysis in the field of chemistry; packaging design; scientific laboratory services; styling, namely, industrial design services; physics research; surveying | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; hygienic services for human beings or animals; agriculture services, namely, providing recommendations for plant and soil nutrition supplements; hospitals; health centers, namely, hospital services for persons with physical and/or cognitive disabilities or impairments; medical advice for individuals with disabilities; pharmacy advice, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; veterinary assistance;, namely, emergency veterinary treatment services; rehabilitation for substance abuse patients; health care; health counseling; medical clinic services; speech therapy services; services of a psychologist; telemedicine services; therapy services, namely, physical therapy services; pharmacists' services to make up prescriptions; nursing, medical; physical therapy; plastic surgery | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mapix S.à.r.l
- Other trademarks owned by Mapix S.à.r.l
- Other trademarks owned by Mapix S.à.r.l
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SANTONIKA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 8, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 18, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 18, 2025 | INPC | INVALIDATION PROCESSED | — |
| Dec 20, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 19, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 4, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 18, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 18, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 3, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 3, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 6, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 11, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 11, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2016 | NAUD | NOTICE OF UNRESPONSIVE AMENDMENT - MAILED | — |
| Oct 9, 2016 | NAUD | REPORT UNRESPONSIVE AMENDMENT - COMPLETED | — |
| Sep 27, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 6, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 6, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 6, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 5, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |